These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38961380)

  • 21. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
    Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
    Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
    Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New advances in the subtyping of systemic amyloidosis].
    Sun WY; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Throughput In Situ DDA Analysis of Neuropeptides by Coupling Novel Multiplex Mass Spectrometric Imaging (MSI) with Gas-Phase Fractionation.
    OuYang C; Chen B; Li L
    J Am Soc Mass Spectrom; 2015 Dec; 26(12):1992-2001. PubMed ID: 26438126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatially Resolved Neuropeptide Characterization from Neuropathological Formalin-Fixed, Paraffin-Embedded Tissue Sections by a Combination of Imaging MALDI FT-ICR Mass Spectrometry Histochemistry and Liquid Extraction Surface Analysis-Trapped Ion Mobility Spectrometry-Tandem Mass Spectrometry.
    Cintron-Diaz YL; Gomez-Hernandez ME; Verhaert MMHA; Verhaert PDEM; Fernandez-Lima F
    J Am Soc Mass Spectrom; 2022 Apr; 33(4):681-687. PubMed ID: 35258288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A stepwise data interpretation process for renal amyloidosis typing by LMD-MS.
    Ke M; Li X; Wang L; Yue S; Zhao B
    BMC Nephrol; 2022 Apr; 23(1):144. PubMed ID: 35418036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis.
    Lim A; Prokaeva T; McComb ME; Connors LH; Skinner M; Costello CE
    Protein Sci; 2003 Aug; 12(8):1775-85. PubMed ID: 12876326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accurate Quantitative Proteomic Analyses Using Metabolic Labeling and High Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS).
    Pfammatter S; Bonneil E; McManus FP; Thibault P
    J Proteome Res; 2019 May; 18(5):2129-2138. PubMed ID: 30919622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fully automated FAIMS-DIA mass spectrometry-based proteomic pipeline.
    Reilly L; Lara E; Ramos D; Li Z; Pantazis CB; Stadler J; Santiana M; Roberts J; Faghri F; Hao Y; Nalls MA; Narayan P; Liu Y; Singleton AB; Cookson MR; Ward ME; Qi YA
    Cell Rep Methods; 2023 Oct; 3(10):100593. PubMed ID: 37729920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confirming the Diagnosis of Amyloidosis.
    Wisniowski B; Wechalekar A
    Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Field Asymmetric Waveform Ion Mobility Spectrometry in Nontargeted Bottom-up Proteomics of Dried Blood Spots.
    Rosting C; Yu J; Cooper HJ
    J Proteome Res; 2018 Jun; 17(6):1997-2004. PubMed ID: 29707944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid analysis by ion mobility spectrometry combined with mass spectrometry: A brief update with a perspective on applications in the clinical laboratory.
    Dubland JA
    J Mass Spectrom Adv Clin Lab; 2022 Jan; 23():7-13. PubMed ID: 34988541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined MALDI Mass Spectrometry Imaging and Parafilm-Assisted Microdissection-Based LC-MS/MS Workflows in the Study of the Brain.
    Quanico J; Franck J; Wisztorski M; Salzet M; Fournier I
    Methods Mol Biol; 2017; 1598():269-283. PubMed ID: 28508367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked biochemical difference in amyloid proportion between intra- and extraocular tissues in a liver-transplanted patient with hereditary ATTR amyloidosis.
    Yoshinaga T; Yazaki M; Kametani F; Sekijima Y; Iesato Y; Miyahara T; Tsuchiya-Suzuki A; Sano K; Higuchi K; Ikeda SI
    Amyloid; 2017 Mar; 24(1):17-23. PubMed ID: 28081655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nontarget analysis of urine by electrospray ionization-high field asymmetric waveform ion mobility-tandem mass spectrometry.
    Beach DG; Gabryelski W
    Anal Chem; 2011 Dec; 83(23):9107-13. PubMed ID: 21978137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort.
    Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J
    Intern Med J; 2022 Jan; 52(1):69-78. PubMed ID: 32981138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: An imaging mass spectrometry study.
    Shintani-Domoto Y; Sugiura Y; Ogawa M; Sugiyama E; Abe H; Sakatani T; Ohashi R; Ushiku T; Fukayama M
    PLoS One; 2022; 17(10):e0275993. PubMed ID: 36240260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Differential Ion Mobility Device Expands the Depth of Proteome Coverage and the Sensitivity of Multiplex Proteomic Measurements.
    Pfammatter S; Bonneil E; McManus FP; Prasad S; Bailey DJ; Belford M; Dunyach JJ; Thibault P
    Mol Cell Proteomics; 2018 Oct; 17(10):2051-2067. PubMed ID: 30007914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.
    Michno W; Wehrli PM; Koutarapu S; Marsching C; Minta K; Ge J; Meyer SW; Zetterberg H; Blennow K; Henkel C; Oetjen J; Hopf C; Hanrieder J
    J Neurochem; 2022 Feb; 160(4):482-498. PubMed ID: 34882796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-field asymmetric waveform ion mobility spectrometry for mass spectrometry-based proteomics.
    Swearingen KE; Moritz RL
    Expert Rev Proteomics; 2012 Oct; 9(5):505-17. PubMed ID: 23194268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.